Q2 2026 · Form 13F LedgerData source: SEC EDGAR  
H

HOLDER.TOP

Who owns what — the quarterly ledger of U.S. institutional holdings.
EN · 简 · 繁
Funds / Kynam Capital Management, LP
Form 13F · Q2 2026

Kynam Capital Management, LP

CIK 1907884Filed 2026-08-1413F-HR View the filing on EDGAR ↗
$1.8B
Reported book value
32
Positions
12
Quarters on record
Top 50
Positions

Kynam Capital Management, LP — holdings

Top 32 positions of 32, ranked by reported value. Share change is versus the previous quarter.
#SecuritySharesShare Δ QoQValue% of book
1CLDX Celldex Therapeutics Inc New5.3M−8.9%$198M10.9%
2SNDX Syndax Pharmaceuticals Inc8.1M+0.0%$176M9.7%
3PCVX Vaxcyte Inc2.9M+0.0%$170M9.4%
4COGT Cogent Biosciences Inc3.7M−9.2%$142M7.8%
5VERA Vera Therapeutics Inc2.9M−15.0%$124M6.9%
6VRDN Viridian Therapeutics Inc6.5M+175.6%$119M6.6%
7TVTX Travere Therapeutics Inc2.0M+27.5%$114M6.3%
8BEAM Beam Therapeutics Inc2.8M−22.9%$97M5.4%
9URGN Urogen Pharma Ltd2.4M+8.3%$90M5.0%
10LEGN Legend Biotech Corp3.0M+90.4%$87M4.8%
11CTMX Cytomx Therapeutics Inc.21.7M+44.6%$81M4.5%
12RLAY Relay Therapeutics Inc3.3M+131.7%$62M3.4%
13CGEM Cullinan Therapeutics Inc3.1M+0.0%$57M3.1%
14MBX Mbx Biosciences Inc934,799+0.0%$52M2.9%
15IMCR Immunocore Hldgs Plc1.4M+55.4%$44M2.4%
16NRIX Nurix Therapeutics Inc1.2M+0.0%$29M1.6%
17STRO Sutro Biopharma Inc872,558+0.0%$29M1.6%
18BCRX Biocryst Pharmaceuticals Inc2.5M−55.6%$25M1.4%
19PHVS Pharvaris N V661,795+3.3%$23M1.3%
20SMMT Summit Therapeutics Inc1.2M—$17M1.0%
21PRLD Prelude Therapeutics Inc2.4M+51.6%$13M0.7%
22INSM Insmed Inc100,000—$11M0.6%
23BNR Burning Rock Biotech Ltd1.2M+0.9%$11M0.6%
24GERN Geron Corp6.8M+0.0%$9M0.5%
25AMARIN CORP PLC Amarin Corp Plc532,982+12.8%$8M0.5%
26ALEC Alector Inc3.8M+90.4%$8M0.4%
27PBLS Parabilis Medicines Inc250,000—$7M0.4%
28CRBU Caribou Biosciences Inc2.5M+0.0%$4M0.2%
29PROQR THRAPEUTICS N V Proqr Thrapeutics N V1.6M+0.0%$3M0.2%
30CADL Candel Therapeutics Inc96,741−51.6%$996,4320.1%
31ENGN Engene Therapeutics Inc457,855—$792,0890.0%
32TRAW Traws Pharma Inc84,400—$71,1750.0%
Source: Form 13F filings via SEC EDGAR. Positions as of Jun 30, 2026. Options (put/call) are excluded from share counts.